{
    "medical_history": {
        "chief_complaint": "Development of leprosy and type 1 leprosy reactions after treatment with infliximab.",
        "history_of_present_illness": "Patient 1, a 60-year-old male, developed a rash on one extremity one month after the first dose of infliximab, which progressed to all extremities. A biopsy suggested borderline lepromatous HD. Type 1 reactions characterized by malaise and exacerbation of lesions occurred one month after starting MDT. Patient 2, a 76-year-old female, had multiple nodules and plaques observed at admission. She reported receiving irregular infliximab therapy due to a skin rash. T1R manifested one month after starting MDT.",
        "past_medical_history": "Patient 1 had diffuse polyarthritis treated with corticosteroids, methotrexate, and hydroxychloroquine; type 1 diabetes mellitus; hypertension; and cardiovascular disease. Patient 2 had a long history of rheumatoid arthritis with bony deformities and severe secondary shoulder degeneration, treated variably with prednisone, hydroxychloroquine, and methotrexate.",
        "family_history": "Patient 2's husband had considerable exposure to armadillos and reportedly exhibited similar symptoms but refused medical attention; no other family history mentioned.",
        "social_history": "Patient 1 had never traveled outside the United States and had no significant history of contact with armadillos. Patient 2's husband hunted armadillos. For both patients, no other relevant social history mentioned."
    }
}